The absence of any novel coronavirus exhibiting sustained human-to-human transmission or pandemic-scale virulence as of September 2026 drives the 96.2% market-implied probability against a new outbreak this year. Global genomic surveillance by agencies like the WHO and CDC shows no exponential case clusters or high-risk spillovers from animal reservoirs, consistent with baseline circulation patterns of known strains rather than the rapid mutation and superspreader events seen in prior pandemics. While model uncertainty persists around zoonotic jumps or undetected variants, current observational data and historical frequency of coronavirus emergence support trader consensus. Key upcoming factors include routine genomic reporting cycles that could flag shifts in transmissibility or severity thresholds.